Document:

EX-4.1

 Exhibit 4.1 
  

 
 STOCKHOLDERS AGREEMENT 

of 
 BRIGHTVIEW
HOLDINGS, INC. 
 Dated as of June 27, 2018 
  

 

 TABLE OF CONTENTS 

 

					
	 	  	Page	 
	 ARTICLE I Definitions
	  	 	1	 
		
	 SECTION 1.1. Definitions
	  	 	1	 
	 SECTION 1.2. Construction
	  	 	5	 
		
	 ARTICLE II Corporate Governance
	  	 	5	 
		
	 SECTION 2.1. Board of Directors
	  	 	5	 
	 SECTION 2.2. Committees
	  	 	8	 
	 SECTION 2.3. Consent Rights
	  	 	8	 
	 SECTION 2.4. Controlled Company
	  	 	10	 
	 SECTION 2.5. Permitted Disclosure
	  	 	10	 
		
	 ARTICLE III Information
	  	 	10	 
		
	 SECTION 3.1. Books and Records; Access; Certain Reports
	  	 	10	 
		
	 ARTICLE IV Miscellaneous
	  	 	11	 
		
	 SECTION 4.1. Termination
	  	 	11	 
	 SECTION 4.2. Indemnification
	  	 	11	 
	 SECTION 4.3. Amendments and Waivers
	  	 	13	 
	 SECTION 4.4. Successors, Assigns and Transferees
	  	 	13	 
	 SECTION 4.5. Third Parties
	  	 	13	 
	 SECTION 4.6. Notices
	  	 	13	 
	 SECTION 4.7. Further Assurances
	  	 	14	 
	 SECTION 4.8. Entire Agreement
	  	 	14	 
	 SECTION 4.9. Restrictions on Other Agreements; Bylaws
	  	 	15	 
	 SECTION 4.10. Delays or Omissions
	  	 	15	 
	 SECTION 4.11. Governing Law; Jurisdiction; Waiver of Jury Trial
	  	 	15	 
	 SECTION 4.12. Severability
	  	 	16	 
	 SECTION 4.13. Enforcement
	  	 	16	 
	 SECTION 4.14. Titles and Subtitles
	  	 	16	 
	 SECTION 4.15. No Recourse
	  	 	16	 
	 SECTION 4.16. Counterparts; Facsimile Signatures
	  	 	16	 
	 SECTION 4.17. Effectiveness
	  	 	16	 

 Exhibits 
 Exhibit
A — Assignment and Assumption Agreement 

  
 - i - 

 STOCKHOLDERS AGREEMENT 

OF 
 BRIGHTVIEW HOLDINGS, INC.

 This STOCKHOLDERS AGREEMENT (as the same may be amended from time to time in accordance with its terms, the “Agreement”)
is entered into as of June 27, 2018, by and among BrightView Holdings, Inc., a Delaware corporation (the “Company”), and each of the stockholders of the Company whose name appears on the signature pages hereto (each, a
“Stockholder” and collectively, the “Stockholders”). 
 RECITALS 

WHEREAS, the Company is currently contemplating an underwritten initial public offering (the “IPO”) of shares of its Common
Stock; and 
 WHEREAS, in connection with, and effective upon, the date of the pricing of the IPO (the “Pricing Date”), the
parties hereto desire to enter into this Agreement to govern certain of their rights, duties and obligations with respect to their ownership of Common Stock after the Pricing Date. 

NOW, THEREFORE, in consideration of the mutual covenants contained herein and other good and valuable consideration, the receipt and
sufficiency of which are hereby acknowledged, the parties to this Agreement hereby agree as follows: 
 ARTICLE I 

DEFINITIONS 

SECTION 1.1. Definitions. Capitalized terms used herein shall have the following meanings: 

“Affiliate” shall mean, (i) with respect to any Person (other than an Investor), an “affiliate” as defined in
Rule 405 of the regulations promulgated under the Securities Act, and (ii) with respect to an Investor, an “affiliate” as defined in Rule 405 of the regulations promulgated under the Securities Act and any investment fund, vehicle or
holding company of which such Investor or an Affiliate of such Investor serves as the general partner, managing member or discretionary manager or advisor; provided, however, that notwithstanding the foregoing, (x) except as used
in Section 4.2, an Affiliate of an Investor shall not include any Portfolio Company or other investment of any Person or such Investor or any investment fund, vehicle or holding company or any investment fund, vehicle or
holding company or any limited partners of such Investor and (y) an Investor or any of its Affiliates shall not be considered an Affiliate of the other Investor. 

“Agreement” shall have the meaning set forth in the Preamble. 

  
 - 1 - 

 “beneficial owner” or “beneficially own” shall have the meaning
set forth in Rule 13d-3 under the Exchange Act; provided, however, that no Stockholder shall be deemed to beneficially own any securities of the Company held by any other Stockholder solely by
virtue of the provisions of this Agreement (other than this definition which shall be deemed to be read for this purpose without the proviso hereto). 

“Board” shall mean the board of directors of the Company. 

“Business Day” shall mean any day that is not a Saturday, a Sunday or other day on which banks are required or authorized by
Law to be closed in the City of New York. 
 “Bylaws” shall mean the Amended and Restated Bylaws of the Company, as in
effect on the Closing Date and as the same may be amended, supplemented or otherwise modified from time to time in accordance with the terms thereof, the terms of the Charter and the terms of this Agreement. 

“Change in Control” shall mean any transaction or series of related transactions (whether by merger, consolidation,
recapitalization, liquidation or sale or transfer of Common Stock or assets (including equity securities of the Subsidiaries) or otherwise) as a result of which any Person or group, within the meaning of Section 13(d)(3) of the Exchange Act
(other than (x) the Investors and their respective Affiliates, any group of which the foregoing are members and any other members of such a group and (y) an employee benefit plan (or trust forming a part thereof) maintained by the Company
or its controlled Affiliates), obtains ownership, directly or indirectly, of (i) Common Stock that represent more than 50% of the total voting power of the outstanding capital stock of the Company or applicable successor entity or (ii) all
or substantially all of the assets of the Company and its Subsidiaries on a consolidated basis. For purposes of this definition, the term “Affiliates” shall include Portfolio Companies. 

“Charter” shall mean the Third Amended and Restated Certificate of Incorporation of the Company, as in effect on the Closing
Date and as the same may be amended, supplemented or otherwise modified from time to time in accordance with the terms thereof and the terms of this Agreement. 

“Closing Date” shall mean the date of completion of the IPO. 

“Common Stock” shall mean the common stock, par value $0.01 per share, of the Company and any securities issued in respect
thereof, or in substitution therefor, in connection with any stock split, dividend or combination, or any reclassification, recapitalization, merger, consolidation, exchange or other similar reorganization. 

“Company” shall have the meaning set forth in the Preamble. 

“control” (including the terms “controlling”, “controlled by” and “under common
control with”), with respect to the relationship between or among two or more Persons, shall mean the possession, directly or indirectly, of the power to direct or cause the direction of the affairs or management of a Person, whether
through the ownership of voting securities, as trustee or executor, by contract or otherwise. 
 “Director” shall mean any
member of the Board. 

  
 - 2 - 

 “Equity Securities” shall mean any and all shares of (i) Common Stock,
(ii) preferred stock of the Company, and (iii) any equity securities (including, without limitation, preferred stock) of the Company convertible into, or exchangeable or exercisable for, any of the foregoing shares, and options, warrants
or other rights to acquire any of the foregoing shares or other securities. In the event any direct or indirect Subsidiary of the Company issues directly to any Stockholder any common stock of such Subsidiary or any equity securities of the type
described in clauses (ii) and (iii), the term “Equity Securities” shall also include the common stock and equity securities of the type described in clauses (ii) and (iii) of such Subsidiary. 

“Exchange Act” shall mean the Securities Exchange Act of 1934, as amended from time to time, and the rules and regulations
promulgated pursuant thereto. 
 “Governmental Authority” shall mean any: (i) nation, state, commonwealth, province,
territory, county, municipality, district or other jurisdiction of any nature; (ii) U.S. and other federal, state, local, municipal, foreign or other government; or (iii) governmental or quasi-governmental authority of any nature
(including any governmental division, department, agency, commission, instrumentality, official, organization, unit, body or entity and any court or other tribunal). 

“Indemnification Agreement” shall mean the Amended and Restated Indemnification Agreement, dated as of May 21, 2014, by
and among the Kohlberg Kravis Roberts & Co. L.P., MSD Capital, L.P., the Parent Limited Partnership, the Company, BrightView GP I, LLC (formerly known as Brickman GP, LLC), BrightView Landscapes, LLC (formerly known as The Brickman Group
Ltd. LLC), as the same may be amended from time to time in accordance with its terms. 
 “Investors” shall mean the MSD
Partners Investor and the KKR Investor. 
 “IPO” shall have the meaning set forth in the Recitals. 

“KKR Designee(s)” shall mean any Director designated by the KKR Investor pursuant to Section 2.1(b)
of this Agreement. 
 “KKR Investor” shall mean KKR BrightView Aggregator L.P. and its Permitted Transferees. 

“Law” shall mean any applicable constitutional provision, statute, act, code, law, regulation, rule, ordinance, order,
decree, ruling, proclamation, resolution, judgment, decision, declaration, or interpretative or advisory opinion or letter of a Governmental Authority. 

“MSD Partners Designee” shall mean the Director designated by the MSD Partners Investor pursuant to
Section 2.1(a) of this Agreement. 
 “MSD Partners Investor” shall mean MSD Valley Investments,
LLC, and its Permitted Transferees. 
 “Parent Limited Partnership” shall mean BrightView Parent, L.P. 

  
 - 3 - 

 “Parent Limited Partnership Agreement” shall mean the Second Amended and
Restated Limited Partnership Agreement of the Parent Limited Partnership, dated as of June 30, 2014, by and among the BrightView GP I, LLC, the Company and each of the parties thereto, as the same may be amended from time to time in accordance
with its terms. 
 “Permitted Transferee” shall mean, with respect to any Investor, any Transferee that is an Affiliate of
such Investor; provided, however, that such Transferee shall agree in a writing in the form attached as Exhibit A hereto to be bound by and to comply with all applicable provisions of this Agreement. 

“Person” shall mean any individual, corporation, partnership, trust, joint stock company, business trust, unincorporated
association, joint venture or other entity of any nature whatsoever. 
 “Portfolio Company” shall mean, with respect to any
Person, a “portfolio company” (as such term is customarily used among institutional investors), or any entity controlled by any “portfolio company”, of such Person or one of its Affiliates. 

“Pricing Date” shall have the meaning set forth in the Recitals. 

“Repurchase” shall mean any redemption, acquisition or other purchase of any shares of Equity Securities. 

“Securities Act” shall mean the Securities Act of 1933, as amended from time to time, and the rules and regulations
promulgated pursuant thereto. 
 “Sponsor Entities” shall mean Kohlberg Kravis Roberts & Co. L.P. and MSD
Partners, L.P. 
 “Stock Exchange” shall mean The New York Stock Exchange or such other securities exchange or interdealer
quotation system on which shares of Common Stock are then listed or quoted. 
 “Stockholder” shall have the meaning set
forth in the Preamble. 
 “Subsidiary” shall mean, with respect to an entity, (i) any corporation of which a majority
of the securities entitled to vote generally in the election of directors thereof, at the time as of which any determination is being made, are owned by such entity, either directly or indirectly, and (ii) any joint venture, general or limited
partnership, limited liability company or other legal entity in which the entity is the record or beneficial owner, directly or indirectly, of a majority of the voting interests or the general partner. 

“Total Number of Directors” shall mean, at any time of determination, the total number of Directors comprising the Board.

 “Transfer” shall mean, directly or indirectly, to sell, transfer, assign, encumber, hypothecate or similarly dispose of,
either voluntarily or involuntarily, or to enter into any contract, option or other arrangement or understanding with respect to the sale, transfer, 

  
 - 4 - 

 
assignment, encumbrance, hypothecation or similar disposition of, any shares of Equity Securities beneficially owned by a Person or any interest in any shares of Equity Securities beneficially
owned by a Person. In the event that any Investor that is a corporation, partnership, limited liability company or other legal entity (other than an individual, trust or estate) ceases to be controlled by the Person controlling such Investor or a
Permitted Transferee thereof, such event shall be deemed to constitute a “Transfer” subject to the restrictions on Transfer contained or referenced herein. 

“Transferee” shall mean any Person to whom any Stockholder or any Transferee thereof Transfers Equity Securities of the
Company in accordance with the terms hereof. 
 “Voting Securities” shall mean, at any time of determination, shares of any
class of Equity Securities of the Company that are then entitled to vote generally in the election of Directors. 

SECTION 1.2. Construction. Whenever the context requires, the gender of all words used in this Agreement includes the
masculine, feminine and neuter forms and the singular form of words shall include the plural and vice versa. All references to Articles and Sections refer to articles and sections of this Agreement. Whenever the words “include,”
“includes” or “including” are used in this Agreement, they shall be deemed to be followed by the words “without limitation.” This Agreement shall be construed without regard to any presumption or rule requiring
construction or interpretation against the party drafting or causing any instrument to be drafted. Any percentage set forth herein shall be deemed to be automatically adjusted without any action on the part of any party hereto to take into account
any stock split, stock dividend or similar transaction occurring after the date of this Agreement so that the rights provided to the Stockholders shall continue to apply to the same extent such rights would have applied absent such stock split,
stock dividend or similar transaction. 
 ARTICLE II 

CORPORATE GOVERNANCE 

SECTION 2.1. Board of Directors. 

(a) Following the Pricing Date, the MSD Partners Investor shall have the right, but not the obligation, to nominate to the Board, one
(1) Director, so long as the MSD Partners Investor and its Affiliates collectively beneficially own 50% or more of the shares of Common Stock owned by the MSD Partners Investor and its Affiliates as of the Pricing Date. MSD Partners Investor
may elect upon written notice to the Company to terminate its rights under this Section 2.1 at any time. 
 (b)
Following the Pricing Date, the KKR Investor shall have the right, but not the obligation, to nominate to the Board a number of designees equal to at least: (i) a majority of the Total Number of Directors, so long as the KKR Investor and its
Affiliates collectively beneficially own 50% or more of the outstanding shares of Common Stock; (ii) 40% of the Total Number of Directors, in the event that the KKR Investor and its Affiliates collectively beneficially own 40% or more, but less than
50%, of the outstanding shares of Common Stock; (iii) 30% of the Total Number of Directors, in the event that the KKR Investor and its Affiliates 

  
 - 5 - 

 
collectively beneficially own 30% or more, but less than 40%, of the outstanding shares of Common Stock; (iv) 20% of the Total Number of Directors, in the event that the KKR Investor and its
Affiliates collectively beneficially own 20% or more, but less than 30%, of the outstanding shares of Common Stock; and (v) 10% of the Total Number of Directors, in the event that the KKR Investor and its Affiliates collectively beneficially own 5%
or more, but less than 20%, of the outstanding shares of Common Stock. For purposes of calculating the number of Directors that the KKR Investor is entitled to designate pursuant to the immediately preceding sentence, any fractional amounts shall
automatically be rounded up to the nearest whole number (e.g., one and one quarter (1 and 1/4) Directors shall equate to two (2) Directors), and any such calculations shall be made after taking into account any increase in the Total Number of
Directors. 
 (c) Effective as of the Pricing Date, the MSD Partners Designee shall initially be David R. Caro and the KKR Designees shall
initially be Paul E. Raether and Joshua T. Weisenbeck. 
 (d) The Company agrees, to the fullest extent permitted by applicable Law
(including with respect to fiduciary duties under Delaware law), to include the individuals designated pursuant to this Section 2.1 in the slate of nominees recommended by the Board for election at any meeting of
stockholders called for the purpose of electing Directors and to use its best efforts to cause the election of each such designee to the Board, including nominating each such individual to be elected as a Director as provided herein, recommending
such individual’s election and soliciting proxies or consents in favor thereof. 
 (e) In the event that the MSD Partners Investor or
the KKR Investor, as applicable, has nominated less than the total number of designees that the MSD Partners Investor or the KKR Investor, as applicable, shall be entitled to nominate pursuant to Section 2.1(a) or
Section 2.1(b), as applicable, then the MSD Partners Investor or the KKR Investor, as applicable, shall have the right, at any time, to nominate such additional designee(s) to which it is entitled, in which case, the
Company and the Directors shall take all necessary corporate action, to the fullest extent permitted by applicable Law (including with respect to fiduciary duties under Delaware law), to (x) enable the MSD Partners Investor or the KKR Investor,
as applicable, to nominate and effect the election or appointment of such additional individuals, whether by increasing the size of the Board or otherwise, and (y) designate such additional individuals nominated by the MSD Partners Investor or
the KKR Investor, as applicable, to fill such newly created vacancies or to fill any other existing vacancies. 
 (f) In the event that a
vacancy is created at any time by the death, disability, retirement, resignation or removal (with or without cause) of any Director designated by the MSD Partners Investor or the KKR Investor, as applicable, pursuant to this
Section 2.1, the remaining Directors and the Company shall, to the fullest extent permitted by applicable Law (including with respect to fiduciary duties under Delaware law), cause the vacancy created thereby to be filled
by a new designee of the MSD Partners Investor or the KKR Investor, as applicable, who designated such Director as soon as possible, and the Company hereby agrees to take, to the fullest extent permitted by applicable Law (including with respect to
fiduciary duties under Delaware law), at any time and from time to time, all actions necessary to accomplish the same. 

  
 - 6 - 

 (g) In the event that the MSD Partners Investor or the KKR Investor, as applicable, shall cease
to have the right to designate a Director pursuant to this Section 2.1, the designee of such Investor selected by such Investor shall (i) at the request of a majority of the Directors then in office or the Chairman of
the Board, resign immediately or such Investor shall take all action necessary to remove such designee or (ii) if no such request is made, continue to serve until his or her term expires at the next annual meeting of stockholders of the
Company. In the event such designee resigns or is removed at the request of a majority of the Directors then in office or the Chairman of the Board, the Directors remaining in office shall be entitled to decrease the size of the Board to eliminate
such vacancy and no consent under Section 2.3(b) shall be required in connection with such decrease. 
 (h) The MSD
Partners Investor or the KKR Investor shall have the right to representation on the board of directors or other similar governing body (or any committee thereof in the case of the KKR Investor) of any Subsidiary of the Company in proportion to their
representation on the Board; provided that the MSD Partners Investor shall have such right to representation only if and to the extent a KKR Designee is serving on any such board of directors or other similar governing body. 

(i) The Company shall reimburse the MSD Partners Designee and the KKR Designee(s), as applicable, for their reasonable out-of-pocket expenses incurred by them in connection with performing his or her duties as a member of the Board (or any committee thereof), including the reasonable out-of-pocket expenses incurred by such person for attending meetings of the Board (or any committee thereof), or in connection with their service on the board or other
similar governing body of any Subsidiary of the Company (or any committee thereof). 
 (j) Each of the Stockholders agrees to vote, or act by
written consent with respect to, all Voting Securities beneficially owned by it, at each annual or special meeting of stockholders of the Company at which Directors are to be elected, or to take all actions by written consent in lieu of any such
meeting as are necessary, to cause the MSD Partners Designee and the KKR Designee(s) to be elected to the Board. Each of the Stockholders agrees to use its commercially reasonable efforts to cause the election of each such designee to the Board,
including nominating such individuals to be elected as members of the Board. In the event that a vacancy is created at any time by the death, disability, retirement, resignation or removal (with or without cause) of any Director designated pursuant
to Section 2.1(a) or Section 2.1(b), as applicable, and the remaining Directors pursuant to Section 2.1(f) have caused the vacancy created thereby to be filled by a new
designee of the MSD Partners Investor or the KKR Investor, as applicable, then in such case each Stockholder hereby agrees to take, at any time and from time to time, all actions necessary to accomplish the same. Upon the written request of the
MSD Partners Investor or the KKR Investor, as applicable, each other Stockholder shall vote, or act by written consent with respect to, all Voting Securities beneficially owned by it and otherwise take or cause to be taken all actions necessary to
remove any Director designated by such Stockholders and to elect any replacement Director designated as provided in this Section 2.1. Unless the MSD Partners Investor or the KKR Investor shall otherwise request in
writing, no other Stockholder shall take any action to cause the removal of any Directors designated by such Stockholder. The provisions of this section 2.1(j) shall be terminable at the option of the MSD Partners Investor upon the earlier to occur
of (i) a MSD Partners Designee no longer serving on 

  
 - 7 - 

 
the Board, (ii) the combined voting power of Common Stock held by the Investors representing less than 50% of the total voting power of the Common Stock outstanding and the Company no longer
qualifies as a “controlled company” within the meaning of Stock Exchange rules or (iii) the second anniversary of the Closing Date. 

(k) The rights of the Stockholders pursuant to this Section 2.1 are personal to the Stockholders and shall not be
exercised by any Transferee other than a Permitted Transferee. 
 SECTION 2.2. Committees . For so long as the KKR Investor
has the right to designate at least one (1) Director pursuant to Section 2.1, the KKR Investor shall have the right, but not the obligation, to designate one member of each committee of the Board; provided that the right of any Director to
serve on a committee shall be subject to applicable Law and the Company’s obligation to comply with any applicable independence requirements of the Stock Exchange. 

SECTION 2.3. Consent Rights. 

(a) Until the earlier of (x) the date on which the MSD Partners Investor and its Affiliates collectively beneficially own less than 5% of
the outstanding shares of Common Stock and (y) the date on which the rights of the MSD Partners Investor pursuant to Section 2.1 are terminated, the following actions by the Company or any of its Subsidiaries shall
require the approval, in addition to the Board’s approval (or the approval of the required governing body of any Subsidiary of the Company), of the MSD Partners Investor: 

(i) any redemption, acquisition or other purchase of any shares of Equity Securities (a “Repurchase”) from the KKR
Investor or any of its Affiliates other than on a pro rata basis; and 
 (ii) any other transaction with or involving the KKR
Investor or any of its Affiliates, other than (A) a Transfer to a Permitted Transferee, (B) transactions pursuant to any agreement in effect on the Closing Date, including, without limitation, the Parent Limited Partnership Agreement and
the Indemnification Agreement, and any amendment, termination or material waiver under such agreements, (C) customary indemnification agreements with Directors, (D) transactions with Capstone Consulting LLC and its Subsidiaries for
services rendered to the Company or its Subsidiaries (other than issuances of Equity Securities or capital stock or other securities of any direct or indirect Subsidiary of the Company to Capstone Consulting LLC or its Subsidiaries not made in
compliance with the terms of this Agreement), (E) transactions with KKR Capital Markets LLC for services rendered to the Company or its Subsidiaries (other than issuances of Equity Securities or capital stock or other securities of any direct or
indirect Subsidiary of the Company to KKR Capital Markets LLC not made in compliance with the terms of this Agreement), and (F) any transaction or series of related transactions in the ordinary course of business and on arms-length third-party
terms. 

  
 - 8 - 

 (b) For so long as the KKR Investor and its Affiliates collectively beneficially own at least 25%
of the outstanding shares of Common Stock, the following actions by the Company or any of its Subsidiaries shall require the approval, in addition to any approval by the stockholders of the Company or the Board’s approval (or the approval of
the required governing body of any Subsidiary of the Company), of the KKR Investor: 
 (i) entering into or effecting a
Change in Control; 
 (ii) entering into any agreement providing for the acquisition or divestiture of assets or equity
security of any Person, in each case providing for aggregate consideration in excess of $25 million; 
 (iii) entering
into any joint venture or similar business alliance having a fair market value as of the date of formation thereof (as reasonably determined by the Board) in excess of $25 million; 

(iv) initiating a voluntary liquidation, dissolution, receivership, bankruptcy or other insolvency proceeding involving the
Company or any Subsidiary of the Company that is a “significant subsidiary” as defined in Rule 1-02 of Regulation S-X under the Exchange Act; 

(v) any material change in the nature of the business of the Company and its Subsidiaries, taken as a whole; 

(vi) a Repurchase other than (x) open market Repurchases made pursuant to a share repurchase plan approved by the Board or
(y) Repurchases in accordance with any existing compensation plan of the Company or any Subsidiary of the Company or a Repurchase from an employee in connection with such employee’s termination of employment with the Company or any
Subsidiary of the Company or otherwise in accordance with the Parent Limited Partnership Agreement or such employee’s management stockholder’s agreement with the Company, if any; 

(vii) the incurrence of indebtedness for borrowed money (including through the issuance of debt securities or the guarantee of
indebtedness of another Person) in an aggregate principal amount in excess of $50 million in any transaction or series of related transactions, other than borrowings under the Company’s revolving credit facility (or amendments, extensions,
or replacements thereof); 
 (viii) terminating the employment of the Chief Executive Officer of the Company or hiring a new
Chief Executive Officer of the Company; 
 (ix) subject to Section 2.1, any increase or decrease in
the size or composition of the Board, committees of the Board, and boards and committees of Subsidiaries of the Company; 

  
 - 9 - 

 (x) any transaction with or involving any Affiliate of the Company (other than
the KKR Investor and its Affiliates), other than (A) a Transfer to a Permitted Transferee, (B) transactions pursuant to any agreement in effect on the Closing Date, including, without limitation, the Parent Limited Partnership Agreement
and the Indemnification Agreement, and any amendment, termination or material waiver under such agreements, (C) customary indemnification agreements with Directors and officers of the Company or any Subsidiary, (D) transactions permitted
by Section 2.3(b)(vi)(y) above and other customary compensation arrangements with employees of the Company; and (E) any transaction or series of related transactions in the ordinary course of business and on
arms-length third-party terms and not involving amounts in excess of $5 million per annum. 
 SECTION 2.4. Controlled
Company. 
 (a) The Investors acknowledge and agree that, (i) by virtue of this Article II, they are acting as a “group”
within the meaning of the Stock Exchange rules as of the date hereof, and (ii) by virtue of the combined voting power of Common Stock held by the Investors representing more than 50% of the total voting power of the Common Stock outstanding as
of the Pricing Date, the Company qualifies as a “controlled company” within the meaning of Stock Exchange rules as of the Pricing Date. 

(b) So long as the Company qualifies as a “controlled company” for purposes of Stock Exchange rules, the Company will elect to be a
“controlled company” for purposes of Stock Exchange rules, and will disclose in its annual meeting proxy statement that it is a “controlled company” and the basis for that determination. If the Company ceases to qualify as a
“controlled company” for purposes of Stock Exchange rules, the Investors and the Company will take whatever action may be reasonably necessary in relation to such party, if any, to cause the Company to comply with Stock Exchange rules as
then in effect within the timeframe for compliance available under such rules. 
 SECTION 2.5. Permitted Disclosure. The
MSD Partners Designee is permitted to disclose to the MSD Partners Investor and its Affiliates information about the Company and its Affiliates that he or she receives as a result of being a Director, subject to his or her fiduciary duties under
Delaware law. Each KKR Designee is permitted to disclose to the KKR Investor and its Affiliates information about the Company and its Affiliates that he or she receives as a result of being a Director, subject to his or her fiduciary duties under
Delaware law. 
 ARTICLE III 

INFORMATION 

SECTION 3.1. Books and Records; Access; Certain Reports. 

(a) The Company shall, and shall cause its Subsidiaries to, keep proper books, records and accounts, in which full and correct entries shall be
made of all financial transactions and the assets and business of the Company and each of its Subsidiaries in accordance with generally accepted accounting principles. For so long as the MSD Partners Investor or the KKR 

  
 - 10 - 

 
Investor, as applicable, has the right to designate at least one (1) Director pursuant to Section 2.1, the Company shall, and shall cause its Subsidiaries to,
permit the MSD Partners Investor or the KKR Investor, as applicable, and its designated representatives, at reasonable times and upon reasonable prior notice to the Company, to review the books and records of the Company or any of such Subsidiaries
and to discuss the affairs, finances and condition of the Company or any of such Subsidiaries with the officers of the Company or any such Subsidiary; provided, however, that the Company shall not be required to disclose any privileged
information of the Company so long as the Company has used its best efforts to provide such information to the MSD Partners Investor or the KKR Investor, as applicable, without the loss of any such privilege and notified the MSD Partners Investor or
the KKR Investor, as applicable, that such information has not been provided. 
 (b) So long as the MSD Partners Investor or the KKR
Investor, as applicable, has the right to designate at least one (1) Director pursuant to Section 2.1, the Company shall deliver or cause to be delivered to the MSD Partners Investor or the KKR Investor, as applicable,
at their request: 
 (i) to the extent otherwise prepared by the Company, operating and capital expenditure budgets and
periodic information packages relating to the operations and cash flows of the Company and its Subsidiaries; and 
 (ii) such
other reports and information as may be reasonably requested by the MSD Partners Investor or the KKR Investor, as applicable; 
 provided,
however, that the Company shall not be required to disclose any privileged information of the Company so long as the Company has used its best efforts to enter into an arrangement pursuant to which it may provide such information to the MSD
Partners Investor or the KKR Investor, as applicable, without the loss of any such privilege. 
 ARTICLE IV 

MISCELLANEOUS 

SECTION 4.1. Termination. Subject to the early termination of any provision as a result of an amendment to this Agreement
agreed to by the Board and the Stockholders as provided under Section 4.3, (i) the provisions of Article II shall, with respect to each Stockholder, terminate as provided in the applicable Section of Article II, (ii) the provisions of
Article III shall, with respect to each Stockholder, terminate as provided in the applicable Section of Article III, and (iii) this Article IV shall not terminate. Nothing herein shall relieve any party from any liability for the breach of
any of the agreements set forth in this Agreement. 
 SECTION 4.2. Indemnification. 

(a) The Company agrees to indemnify and hold harmless each Stockholder, their respective directors, officers, partners, members, direct and
indirect owners, managers, Affiliates and controlling persons (each, an “Stockholder Indemnitee”) from and against any and all liability, including, without limitation, all obligations, costs, fines, claims, actions, injuries,
demands, suits, judgments, proceedings, investigations, arbitrations (including stockholder claims, actions, injuries, demands, suits, judgments, proceedings, investigations or arbitrations) 

  
 - 11 - 

 
and reasonable expenses, including reasonable accountant’s and reasonable attorney’s fees and expenses (together the “Losses”), incurred by such Stockholder Indemnitee
before or after the date of this Agreement to the extent arising out of, resulting from, or relating to (i) such Stockholder Indemnitee’s purchase and/or ownership of any Equity Securities or (ii) any litigation to which any
Stockholder Indemnitee is made a party in its capacity as a stockholder or owner of securities (or as a director, officer, partner, member, manager, Affiliate or controlling person of any Stockholder) of the Company; provided that the
foregoing indemnification rights in this Section 4.2 shall not be available to the extent that (a) any such Losses are incurred as a result of such Stockholder Indemnitee’s willful misconduct or gross negligence;
(b) any such Losses are incurred as a result of non-compliance by such Stockholder Indemnitee with any laws or regulations applicable to any of them; or (c) subject to the rights of contribution
provided for below, to the extent indemnification for any Losses would violate any applicable Law or public policy. For purposes of this Section 4.2, none of the circumstances described in the limitations contained in the
proviso in the immediately preceding sentence shall be deemed to apply absent a final non-appealable judgment of a court of competent jurisdiction to such effect, in which case to the extent any such
limitation is so determined to apply to any Stockholder Indemnitee as to any previously advanced indemnity payments made by the Company under this Section 4.2, then such payments shall be promptly repaid by such Stockholder
Indemnitee to the Company. The rights of any Stockholder Indemnitee to indemnification hereunder will be in addition to any other rights any such party may have under any other agreement or instrument to which such Stockholder Indemnitee is or
becomes a party or is or otherwise becomes a beneficiary or under law or regulation. In the event of any payment of indemnification pursuant to this Section 4.2, to the extent that any Stockholder Indemnitee is indemnified
for Losses, the Company will be subrogated to the extent of such payment to all of the related rights of recovery of the Stockholder Indemnitee to which such payment is made against all other Persons. Such Stockholder Indemnitee shall execute all
papers reasonably required to evidence such rights. The Company will be entitled at its election to participate in the defense of any third party claim upon which indemnification is due pursuant to this Section 4.2 or to
assume the defense thereof, with counsel reasonably satisfactory to such Stockholder Indemnitee unless, in the reasonable judgment of the Stockholder Indemnitee, a conflict of interest between the Company and such Stockholder Indemnitee may exist,
in which case such Stockholder Indemnitee shall have the right to assume its own defense and the Company shall be liable for all reasonable expenses therefor. Except as set forth above, should the Company assume such defense all further defense
costs of the Stockholder Indemnitee in respect of such third party claim shall be for the sole account of such party and not subject to indemnification hereunder. The Company will not without the prior written consent of the Stockholder Indemnitee
(which consent shall not be unreasonably withheld) effect any settlement of any threatened or pending third party claim in which such Stockholder Indemnitee is or could have been a party and be entitled to indemnification hereunder unless such
settlement solely involves the payment of money and includes an unconditional release of such Stockholder Indemnitee from all liability and claims that are the subject matter of such claim. If the indemnification provided for above is unavailable in
respect of any Losses, then the Company, in lieu of indemnifying a Stockholder Indemnitee, shall, if and to the extent permitted by Law, contribute to the amount paid or payable by such Stockholder Indemnitee in such proportion as is appropriate to
reflect the relative fault of the Company and such Stockholder Indemnitee in connection with the actions which resulted in such Losses, as well as any other equitable considerations. 

  
 - 12 - 

 (b) The Company agrees to pay or reimburse (i) the Stockholders for (A) all reasonable
costs and expenses (including reasonable attorneys’ fees, charges, disbursement and expenses) incurred in connection with any amendment, supplement, modification or waiver of or to any of the terms or provisions of this Agreement or any related
agreements and (B) in connection with any stamp, transfer, documentary or other similar taxes, assessments or charges levied by any governmental or revenue authority in respect of this Agreement or any related agreements; and (ii) each
Stockholder for all costs and expenses of such Stockholder (including reasonable attorneys’ fees, charges, disbursement and expenses) incurred in connection with (1) the consent to any departure by the Company or any of its Subsidiaries
from the terms of any provision of this Agreement or any related agreements and (2) the enforcement or exercise by such Stockholder of any right granted to it or provided for hereunder. 

SECTION 4.3. Amendments and Waivers. Except as otherwise provided herein, no modification, amendment, restatement, amendment
and restatement, or waiver of any provision of this Agreement shall be effective without the approval of the Board and each of the MSD Partners Investor and the KKR Investor; provided, however, that any Stockholder may waive (in writing) the benefit
of any provision of this Agreement with respect to itself for any purpose. The failure of any party to enforce any of the provisions of this Agreement shall in no way be construed as a waiver of such provisions and shall not affect the right of such
party thereafter to enforce each and every provision of this Agreement in accordance with its terms. Any written amendment, restatement, amendment and restatement, or waiver to this Agreement that receives the vote or consent of the Stockholders
provided herein need not be signed by all Stockholders, but shall be effective in accordance with its terms and shall be binding upon all Stockholders and any Transferees. 

SECTION 4.4. Successors, Assigns and Transferees. This Agreement shall bind and inure to the benefit of and be enforceable by
the parties hereto and their respective successors and permitted assigns. This Agreement may not be assigned without the express prior written consent of the other parties hereto, and any attempted assignment, without such consents, will be null and
void; provided, however, that each of the MSD Partners Investor and the KKR Investor shall be entitled to assign, in whole or in part, any of its rights hereunder to any of its Permitted Transferees without such prior written consent. 

SECTION 4.5. Third Parties. Except as may otherwise be expressly provided in this Agreement, this Agreement does not create
any rights, claims or benefits inuring to any person that is not a party hereto nor create or establish any third party beneficiary hereto. 

SECTION 4.6. Notices. All notices and other communications required or permitted under this Agreement shall be in writing and
shall be deemed effectively given: (a) when delivered personally by hand to the party to be notified (with written confirmation of receipt), (b) when sent by facsimile or e-mail (with written confirmation
of transmission), (c) when received or rejected by the addressee if sent by registered or certified mail, postage prepaid, return receipt requested, or (d) one Business Day following the day sent by reputable overnight courier (with
written confirmation of receipt), in each case at the following addresses and facsimile numbers (or to such other address or facsimile number as a party may have specified by notice given to the other party pursuant to this provision): 

  
 - 13 - 

	 	(i)	if to the Company, to: 

 BrightView Holdings, Inc. 

401 Plymouth Road 

Suite 500 

Plymouth Meeting, Pennsylvania 19462 

Attention: Jonathan Gottsegen 

Facsimile: (240) 683-2025 

with a copy (which shall not constitute notice) to: 

Simpson Thacher & Bartlett LLP 

425 Lexington Avenue 

New York, New York 10017 

Attention: Joseph H. Kaufman, Esq. 

Fax: (212) 455-2502 

 

	 	(ii)	if to the MSD Partners Investor, to: 

 c/o MSD Partners, L.P. 

645 Fifth Avenue, 21st Floor 

New York, New York 10022 

Attention: Marcello Liguori 

Facsimile: (212) 303-1772 

 

	 	(iii)	if to the KKR Investor, to: 

 KKR BrightView Aggregator L.P. 

c/o Kohlberg Kravis Roberts & Co. L.P. 

9 West 57th Street 

New York, New York 10019 

Attention: Joshua Weisenbeck 

Facsimile: (212) 750-0003 

SECTION 4.7. Further Assurances. At any time or from time to time after the date hereof, the parties agree to cooperate with
each other, and at the request of any other party, to execute and deliver any further instruments or documents and to take all such further action as the other party may reasonably request in order to evidence or effectuate the consummation of the
transactions contemplated hereby and to otherwise carry out the intent of the parties hereunder. 
 SECTION 4.8. Entire
Agreement. This Agreement sets forth the entire understanding of the parties hereto with respect to the subject matter hereof. There are no agreements, representations, warranties, covenants or understandings with respect to the subject matter
hereof or thereof other than those expressly set forth herein and therein. This Agreement supersedes all other prior agreements and understandings between the parties with respect to such subject matter. 

  
 - 14 - 

 SECTION 4.9. Restrictions on Other Agreements; Bylaws. 

(a) Following the date hereof, no Stockholder or any of its Permitted Transferees shall enter into or agree to be bound by any stockholder
agreements with respect to any Equity Securities or any arrangements of any kind with any Person with respect to the voting of any Equity Securities, except pursuant to the agreements specifically contemplated herein and the Parent Limited
Partnership Agreement. 
 (b) The provisions of this Agreement shall be controlling if any such provisions or the operation thereof conflict
with the provisions of the Company’s Bylaws. Each of the parties covenants and agrees to vote their Equity Securities and to take any other action reasonably requested by the Company or any Stockholder to amend the Company’s Bylaws so as
to avoid any conflict with the provisions hereof. 
 SECTION 4.10. Delays or Omissions. It is agreed that no delay or
omission to exercise any right, power or remedy accruing to any party, upon any breach, default or noncompliance by another party under this Agreement, shall impair any such right, power or remedy, nor shall it be construed to be a waiver of any
such breach, default or noncompliance, or any acquiescence therein, or of or in any similar breach, default or noncompliance thereafter occurring. It is further agreed that any waiver, permit, consent or approval of any kind or character on the part
of any party hereto of any breach, default or noncompliance under this Agreement or any waiver on such party’s part of any provisions or conditions of this Agreement, must be in writing and shall be effective only to the extent specifically set
forth in such writing. All remedies, either under this Agreement, by law, or otherwise afforded to any party, shall be cumulative and not alternative. 

SECTION 4.11. Governing Law; Jurisdiction; Waiver of Jury Trial. 

(a) This Agreement shall be governed by, and construed and enforced in accordance with, the laws of the State of Delaware, applicable to
contracts executed in and to be performed entirely within that State, without giving effect to principles or rules of conflict of laws. 

(b) In any judicial proceeding involving any dispute, controversy or claim arising out of or relating to this Agreement, each of the parties
unconditionally accepts the jurisdiction and venue of the Delaware Court of Chancery or, if the Delaware Court of Chancery does not have subject matter jurisdiction over this matter, the Superior Court of the State of Delaware (Complex Commercial
Division) or, if jurisdiction over the matter is vested exclusively in federal courts, the United States District Court for the District of Delaware, and the appellate courts to which orders and judgments thereof may be appealed. In any such
judicial proceeding, the parties agree that in addition to any method for the service of process permitted or required by such courts, to the fullest extent permitted by Law, service of process may be made by delivery provided pursuant to the
directions in Section 4.6. 
 (c) EACH OF THE PARTIES HEREBY WAIVES TO THE FULLEST EXTENT PERMITTED BY APPLICABLE
LAW TRIAL BY JURY IN ANY JUDICIAL PROCEEDING INVOLVING ANY DISPUTE, CONTROVERSY OR CLAIM ARISING OUT OF OR RELATING TO THIS AGREEMENT. 

  
 - 15 - 

 SECTION 4.12. Severability. Whenever possible, each provision of this Agreement
shall be interpreted in such manner as to be effective and valid under applicable Law, but if any provision of this Agreement is held to be invalid, illegal or unenforceable in any respect under any applicable Law in any jurisdiction, such
invalidity, illegality or unenforceability shall not affect any other provision or any other jurisdiction, but this Agreement shall be reformed, construed and enforced in such jurisdiction as if such invalid, illegal or unenforceable provision had
never been contained herein. 
 SECTION 4.13. Enforcement. Each party hereto acknowledges that money damages would not be
an adequate remedy in the event that any of the covenants or agreements in this Agreement are not performed in accordance with its terms, and it is therefore agreed that in addition to and without limiting any other remedy or right it may have, the non-breaching party will have the right to an injunction, temporary restraining order or other equitable relief in any court of competent jurisdiction enjoining any such breach and enforcing specifically the terms
and provisions hereof. 
 SECTION 4.14. Titles and Subtitles. The titles of the sections and subsections of this Agreement
are for convenience of reference only and are not to be considered in construing this Agreement. 
 SECTION 4.15. No
Recourse. This Agreement may only be enforced against, and any claims or cause of action that may be based upon, arise out of or relate to this Agreement, or the negotiation, execution or performance of this Agreement, may be made only against
the entities that are expressly identified as parties hereto, and no past, present or future Affiliate, director, officer, employee, incorporator, member, manager, partner, stockholder, agent, attorney or representative of any party hereto shall
have any liability for any obligations or liabilities of the parties to this Agreement or for any claim based on, in respect of, or by reason of the transactions contemplated hereby. 

SECTION 4.16. Counterparts; Facsimile Signatures. This Agreement may be executed in any number of counterparts, each
of which shall be an original, but all of which together shall constitute one instrument. This Agreement may be executed by facsimile signature(s). 

SECTION 4.17. Effectiveness. This Agreement shall become effective upon the Pricing Date. 

[Remainder of Page Intentionally Left Blank] 

  
 - 16 - 

 IN WITNESS WHEREOF, the parties hereto have executed this Stockholders Agreement as of the date
set forth in the first paragraph hereof. 
  

			
	 BRIGHTVIEW HOLDINGS, INC.

		
	 By:
	 	 /s/ Jonathan M. Gottsegen

		 	 Name:  Jonathan M. Gottsegen

		 	 Title:   Executive Vice President, Chief Legal Officer and Corporate
Secretary

 
			
	 KKR BRIGHTVIEW AGGREGATOR L.P.

		
	 By:
	 	KKR BRIGHTVIEW AGGREGATOR GP LLC, its General Partner
		
	 By:
	 	 /s/ Joshua Weisenbeck

		 	 Name:  Joshua Weisenbeck

		 	 Title:   Vice President

 
			
	 MSD VALLEY INVESTMENTS LLC

		
	 By:
	 	 /s/ Marcello Liguori

		 	 Name:  Marcello Liguori

		 	 Title:   Vice President

 Exhibit A 

Assignment and Assumption Agreement 

Pursuant to the Stockholders Agreement, dated as of June 27, 2018 (the “Stockholders Agreement”), among BrightView
Holdings, Inc., a Delaware corporation (the “Company”), and each of the stockholders of the Company whose name appears on the signature pages listed therein (each, a “Stockholder” and collectively, the
“Stockholders”),                     , (the “Transferor”) hereby assigns to the undersigned the rights that may be
assigned thereunder, and the undersigned hereby agrees that, having acquired Equity Securities as permitted by the terms of the Stockholders Agreement, the undersigned shall assume the obligations of the Transferor under the Stockholders Agreement.
Capitalized terms used but not defined herein shall have the meanings assigned to them in the Stockholders Agreement. 
 Listed below is
information regarding the Equity Securities: 
 Number of Shares of 

Common Stock 
  

 
 [Remainder of
Page Intentionally Left Blank] 

 IN WITNESS WHEREOF, the undersigned has executed this Assumption Agreement as of __________ ___,
________. 
  

	
	[NAME OF TRANSFEROR]
	
	  

	Name:
	Title:
	
	[NAME OF TRANSFEREE]
	
	  

	Name:
	Title:

  

			
	Acknowledged by:
	
	BRIGHTVIEW HOLDINGS, INC.
		
	By:	 	  

		 	Name:
		 	Title:EX-4.2

 Exhibit 4.2 

AMENDMENT NO. 2 
 TO THE 

SECOND AMENDED AND RESTATED 

LIMITED PARTNERSHIP AGREEMENT 
 OF
BRIGHTVIEW PARENT, L.P. 
 June 27, 2018 

This AMENDMENT NO. 2 (“Amendment No. 2”) to the Second Amended and Restated Limited Partnership Agreement,
dated as of June 30, 2014 (the “Agreement”) of BrightView Parent, L.P., a Delaware limited partnership (the “Partnership”), as amended by Amendment No. 1 to the Second Amended and Restated Limited
Partnership Agreement of BrightView Parent, L.P., dated as of July 6, 2016, is made as of the date first written above by BrightView GP I, LLC, a Delaware limited liability company (formerly known as Brickman GP, LLC), as general partner of the
Partnership (the “General Partner”). Capitalized terms used herein and not otherwise defined shall have the meanings given to them in the Agreement. 

W I T N E S S E T H: 
 WHEREAS,
BrightView Holdings, Inc., a Delaware corporation and wholly-owned subsidiary of the Partnership (“BrightView Holdings”), is undertaking an Initial Public Offering and shall be deemed the IPO Corporation under the Agreement; 

WHEREAS, the General Partner, pursuant to Section 4.6 of the Agreement, is obligated to ensure that each of the Limited Partners
receives shares (or other equity securities) in connection with such Initial Public Offering with substantially equivalent economic interest, governance, priority and other rights and privileges as such Limited Partner has with respect to its Units
immediately prior to such Initial Public Offering (except any rights that terminate pursuant to the Agreement upon, or otherwise in connection with, an Initial Public Offering); 

WHEREAS, the General Partner, pursuant to Section 4.6 of the Agreement, has the authority to effect an IPO Conversion, which shall
provide for the distribution of IPO Corporation Shares to, and the issuance of IPO Options to, all Limited Partners; 
 WHEREAS, the General
Partner, pursuant to Section 16.5 of the Agreement, has the authority to amend, modify, supplement or restate the Agreement, without the consent or approval of the other Partners, in its sole discretion, subject to certain limitations; 

WHEREAS, each Limited Partner, pursuant to Section 4.6 of the Agreement, has agreed to cooperate with the General Partner in connection
with an Initial Public Offering and to take all such actions as may reasonably be required by the General Partner in connection therewith to effect, or cause to be effected, such Initial Public Offering; 

WHEREAS, pursuant to Section 13.1 of the Agreement, the General Partner has the authority to determine that the Partnership shall be
dissolved; 

 WHEREAS, the General Partner has determined, pursuant to its authority under Sections 4.6 and
13.1 of the Partnership, that is necessary and appropriate to dissolve the Partnership reasonably promptly after the completion of the IPO Conversion and the Initial Public Offering; 

WHEREAS, the General Partner has determined that it is necessary and appropriate to enter into this Amendment No. 2 in connection with
the Initial Public Offering and the IPO Conversion in order to ensure that each of the Limited Partners receives shares (or other equity securities) of BrightView Holdings in connection with such Initial Public Offering with substantially equivalent
economic interest, governance, priority and other rights and privileges as such Limited Partner has with respect to its Units immediately prior to such Initial Public Offering (except any rights that terminate pursuant to the Agreement upon, or
otherwise in connection with, an Initial Public Offering); and 
 WHEREAS, BrightView Holdings has determined that is necessary and
appropriate for it to become a party to the Agreement in connection with the Initial Public Offering and the IPO Conversion. 
 NOW,
THEREFORE, in consideration of the agreements contained herein, and for other good and valuable consideration acknowledged hereby, the undersigned agrees as follows: 

1. Amendment to Article X. The Agreement is hereby amended by adding a Section 10.7 to read as follows: 

“Section 10.7. Continuation of Rights of Limited Partners Following an Initial Public Offering. 

(a) The Agreement shall survive each of (i) an IPO Conversion undertaken pursuant to Section 4.6 of the Agreement and (ii) the
dissolution, winding-up and termination of the Partnership pursuant to Section 13.1 of the Agreement (the “Dissolution”), subject to the terms and conditions set forth in the Agreement
and this Section 10.7. 
 (b) At the IPO Effective Date, the IPO Corporation shall become a party to the Agreement by execution of
Amendment No. 2. 
 (c) All references to the “Partnership” in the Surviving Provisions shall be deemed to refer to the IPO
Corporation. 
 (d) All references to the “General Partner” in the Surviving Provisions shall be deemed to refer to the board of
directors of the IPO Corporation. 
 (e) All references to a “Limited Partner” or the “Limited Partners” in the
Surviving Provisions shall also be deemed to reference a “Stockholder” or the “Stockholders,” respectively. 
 (f) In
connection with, and effective upon, the IPO Effective Date, other than the Surviving Provisions, all other Articles and Sections in the Agreement shall terminate and 

  
 2 

 
shall have no further effect; provided however that the General Partner shall have the authority to provide for the prompt completion of each of the IPO Conversion, the Initial Public Offering
and the Dissolution and shall enjoy all of the powers, rights and privileges of the General Partner in furtherance of such actions, as if no such amendments shall have be made or become effective.” 

2. Definitions. The following definitions shall be added in proper alphabetical order: 

(a) “Amendment No. 2” means the Amendment No. 2 to the Agreement, dated June 27, 2018 by BrightView GP
I, LLC, as general partner of the Partnership. 
 (b) “IPO Effective Date” means the time at which a registration statement
of the IPO Corporation relating to an Initial Public Offering has been declared effective by the SEC. 
 (c) “Stockholders”
means any Person a party to the Agreement following the IPO Effective Date (other than the IPO Corporation). 
 (d) “Surviving
Provisions” means Articles I, IV (excluding Section 4.4) and XV and Sections 10.4, 10.5, 10.6, 16.2, 16.3, 16.4, 16.5, 16.6, 16.7, 16.10, 16.11 and 16.12 of the Agreement and any additional provisions necessary to give effect to the
foregoing Articles and Sections (including any definition applied to such Article or Section). 
 3. Ratification and Confirmation of the
Agreement. Except as so modified pursuant to this Amendment No. 2, the Agreement is hereby ratified and confirmed in all respects, the other terms and provisions of the Agreement shall not be affected by this Amendment No. 2, and the
Agreement shall continue in full force and effect as amended hereby, notwithstanding the subsequent Dissolution. 
 4. Governing Law.
This Amendment No. 2 shall be construed in accordance with and governed by the Act and the other laws of the State of Delaware, without giving effect to the provisions, policies or principles thereof relating to choice or conflict of laws. 

[remainder of page intentionally left blank] 

  
 3 

 IN WITNESS WHEREOF, the General Partner has caused this Amendment No. 2 to be executed as of
the date first above written. 
  

			
	GENERAL PARTNER:
	
	BrightView GP I, LLC
		
	By:	 	 /s/ Jonathan M. Gottsegen

		 	 Name:  Jonathan M. Gottsegen

		 	 Title:   Assistant Secretary

 BrightView Holdings, Inc., a Delaware corporation, hereby agrees to become a party to the Agreement, as modified by this
Amendment No. 2, and otherwise agrees to be bound in accordance with this Amendment No. 2. 
  

			
	BrightView Holdings, Inc.
		
	By:	 	/s/ Jonathan M. Gottsegen
	Name:	 	Jonathan M. Gottsegen
	Title:	 	Executive Vice President, Chief Legal Officer and Corporate Secretary

 [Signature Page to Amendment No. 2 to Second A&R LPA of BrightView Parent L.P.]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00285-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00285-of-00352.parquet"}]]